Cover Image

Cardio-Nephrology Confluence of the Heart and Kidney in Clinical Practice /

Extending from the outpatient management of cardiovascular and kidney disease, to hospital-based decision making in patients with cardio-renal disease and complex interfaces such as hemodialysis in patients with ventricular assist device support, this book serves as a single reference point for card...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Rangaswami, Janani. (Editor, http://id.loc.gov/vocabulary/relators/edt), Lerma, Edgar V. (Editor, http://id.loc.gov/vocabulary/relators/edt), Ronco, Claudio. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2017.
Edition:1st ed. 2017.
Subjects:
Nephrology.
Cardiology.
Critical care medicine.
Intensive / Critical Care Medicine.
Online Access:https://doi.org/10.1007/978-3-319-56042-7
Table of Contents:
  • PART I: CARDIOVASCULAR DISEASE SPECTRUM IN CHRONIC KIDNEY DISEASE
  • Chapter 1 Endothelial Dysfunction and Nitric Oxide: Albuminuria as a Central Marker
  • Chapter 2 Vascular and Valvular Calcification in Chronic Kidney Disease: Pathogenesis and Clinical Outcomes
  • Chapter 3 Sudden Cardiac Death in CKD and ESKD: Risk Factors, Mechanisms, and Therapeutic Strategies
  • Chapter 4 Coronary Artery Disease in CKD: Traditional and Nontraditional Risk Factors, Diagnosis and Management
  • Chapter 5 CKD Associated Cardiomyopathy: Molecular Mechanisms, Imaging Modalities, Disease Evolution and Interventions
  • PART II: CHRONIC KIDNEY DISEASE AND CAD: TWO SIDES OF THE SAME COIN
  • Chapter 6 CKD as CAD Equivalent: Inflammatory Milieu and Vascular Oxidative Stress
  • Chapter 7 Phosphorus and Mortality: Do we have the Panacea?
  • Chapter 8 Inhibition of the Renin Angiotensin System: How far have we come?
  • Chapter 9 Vitamin D and its Role in CKD and CAD: A Novel Therapeutic Target
  • Chapter 10 Association of Catalytic (Labile) Iron with Cardiovascular Morbidity and Mortality
  • Chapter 11 Erythropoietin and its Cardiovascular Effects
  • PART III: CARDIO-RENAL SYNDROME
  • Chapter 12 Pathophysiology of the Cardio-Renal Syndromes Types 1–5: Updates from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
  • Chapter 13 Hemodynamic Cross Talk in Cardiorenal Syndrome: Era of Biomarkers
  • Chapter 14 Kidney Attack: Is NGAL Set to Take the Stage with Troponins?
  • Chapter 15 Ultrafiltration Therapy in Decompensated Heart Failure
  • Chapter 16 Bioimpedance Vectorial Analyses in Cardio Renal Syndrome
  • Chapter 17 Novel Therapies for Acute Decompensated Heart Failure
  • Chapter 18 Kidney Injury in Patients with Ventricular Assist Devices
  • Chapter 19 Palliation with Dual Burden of Heart and Kidney Failure: An Underutilized Strategy
  • PART IV: CARDIAC EVALUATION OF THE RENAL TRANSPLANT CANDIDATE
  • Chapter 20 Screening Strategies for Coronary Artery Disease (CAD) in Candidates for Kidney Transplants
  • Chapter 21 Cardiac Pre-Operative Evaluation as an Opportunity to Optimize Risk Factors in Kidney Transplant Candidates
  • Chapter 22 Revascularization in Patients on the Renal Transplant List: When and What is Appropriate?
  • Chapter 23 Pulmonary Hypertension in the Potential Kidney Transplant Recipient
  • Chapter 24 Cardiac Surveillance whilst Listed for Renal Transplantation
  • Chapter 25 Post Kidney Transplant Modification of Cardiovascular Risk
  • Ch. 26 Cardiomyopathy in the Potential Kidney Transplant Candidate
  • PART V: ANTICOAGULATION AND ANTIPLATELET THERAPY IN CKD
  • Chapter 27 Anticoagulation in Patients with Atrial Fibrillation and Chronic Kidney Disease
  • Chapter 28 Anticoagulation-Related Nephropathy: Tip of the Iceberg
  • Chapter 29 Impact of Antiplatelet Therapy and Platelet Reactivity Testing on Cardiovascular Outcomes in Patients with Chronic Kidney Disease
  • PART VI: INTERVENTIONAL STRATEGIES IN CARDIOVASCULAR DISEASE IN CKD
  • Chapter 30 Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Intervention vs. Coronary Artery Bypass Graft Surgery
  • Chapter 31 Revascularization Strategies in CKD: Anti-Platelet Therapy, Stent Type, Timing, and Complications of PCI
  • Chapter 32 Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies
  • Chapter 33 Contrast Induced Nephropathy
  • Chapter 34 Acute Kidney Injury after Cardiac Surgery
  • PART VII: THE CARDIORENOMETABOLIC SPECTRUM
  • Chapter 35 Dyslipidemias in CKD and ESKD: Outcomes and Management
  • Chapter 36 The Cardiac Impact of Atherosclerotic Renovascular Disease (ARVD)
  • Chapter 37 Preeclampsia: A Mirror into Future Cardiovascular and Renal Health
  • Chapter 38 Obstructive Sleep Apnea: A Unifying Link between Cardiovascular and Renal Disease
  • PART VIII: DILEMMAS IN HYPERTENSION
  • Chapter 39 Chronic Kidney Disease and BP Goals
  • Chapter 40 Renal Artery Stenosis: Diagnosis and Management
  • Chapter 41 Renal Denervation: Current Opinions and Practice.

Similar Items